Kazia Therapeutics Limited (KZIA) Ownership
KZIA ownership summary
as of October 17, 2026- Institutions
- 32.1% of shares outstanding
- Insiders
- 15.42% of shares outstanding
- Shares outstanding
- 11.4M
- Float
- 9.4M shares available to trade
- Short interest
- 7.56% 1.2M shares short
- Days to cover
- 3.48 short interest up 52.6% vs prior month
- Institutions 32.11%
- Insiders 15.42%
- Other investors 52.47%
KZIA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Boxer Capital Management, LLC | 4.33% | 560K | $4.1M | +560,000 (0.0%) | June 30, 2026 |
| 2 | F.L.Putnam Investment Management | 3.21% | 415K | $3.0M | +272,489 (+191.3%) | June 30, 2026 |
| 3 | Bleichroeder LP | 3.09% | 400K | $2.9M | — | June 30, 2026 |
| 4 | Ikarian Capital, LLC | 3.06% | 396K | $2.9M | +396,201 (0.0%) | June 30, 2026 |
| 5 | Dauntless Investment Group, LLC | 2.74% | 354K | $2.6M | +274,376 (+343.7%) | June 30, 2026 |
| 6 | Stonepine Capital Management Llc | 2.67% | 345K | $2.5M | — | June 30, 2026 |
| 7 | Point72 Asset Management, L.P. | 1.55% | 200K | $1.5M | +300 (+0.1%) | June 30, 2026 |
| 8 | Ensign Peak Advisors Inc | 0.86% | 111K | $803,140 | +110,778 (0.0%) | June 30, 2026 |
| 9 | Millennium Management LLC | 0.78% | 101K | $734,976 | +101,376 (0.0%) | June 30, 2026 |
| 10 | UBS Group AG | 0.63% | 81K | $587,902 | +67,156 (+482.0%) | June 30, 2026 |
| 11 | J. Goldman & Co LP | 0.53% | 68K | $496,560 | +68,491 (0.0%) | June 30, 2026 |
| 12 | ADAR1 Capital Management LLC | 0.48% | 62K | $446,238 | +61,550 (0.0%) | June 30, 2026 |
| 13 | Jane Street Group LLC | 0.44% | 57K | $414,265 | +57,140 (0.0%) | June 30, 2026 |
| 14 | Barclays PLC | 0.44% | 57K | $413,243 | +33,000 (+137.5%) | June 30, 2026 |
| 15 | Susquehanna International Group, LLP | 0.39% | 51K | $366,966 | +50,616 (0.0%) | June 30, 2026 |
| 16 | Cooperman Leon G | 0.39% | 50K | $362,500 | +50,000 (0.0%) | June 30, 2026 |
| 17 | Westside Investment Management, Inc. | 0.37% | 48K | $344,991 | −2,840 (−5.6%) | June 30, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 0.36% | 47K | $337,894 | +45,606 (+4,560.6%) | June 30, 2026 |
| 19 | Marshall Wace Asset Management Ltd | 0.34% | 44K | $320,675 | +44,231 (0.0%) | June 30, 2026 |
| 20 | XTX Topco Ltd | 0.24% | 31K | $226,098 | +31,186 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 17 holders added 2.2M shares and 1 cut 2,840.
KZIA top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Exemplar Growth and Income Ser FD | 1.23% | 159K | $1.2M | +15,000 (+10.4%) | September 30, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.03% | 4,237 | $30,718 | — | August 31, 2026 |
| 3 | ActivePassive International Equity ETF | 0.03% | 3,435 | $24,904 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
KZIA insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-03-20 | Steven Coffey | Buy | $0.60 | 27,000 | $16,200 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
KZIA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns KZIA
Institutional investors own 32.1% of Kazia Therapeutics's shares and insiders 15.42%. The largest holder is Boxer Capital Management, LLC with 4.33% of the shares (560K), as of June 30, 2026. Among the top 20 institutions, 17 added shares and 1 reduced their stake in the latest filings. Short interest is 7.56% of the float, or 3.48 days of average trading volume. The share count rose 8,739.7% since 2014.
Related: KZIA analyst forecast, KZIA key metrics. See the KZIA stock overview for the latest quote and news.
KZIA ownership FAQ
Who owns the most Kazia Therapeutics stock?
The largest shareholders of Kazia Therapeutics are Boxer Capital Management, LLC (4.33%), F.L.Putnam Investment Management (3.21%), Bleichroeder LP (3.09%), Ikarian Capital, LLC (3.06%), Dauntless Investment Group, LLC (2.74%).
What percentage of Kazia Therapeutics is owned by institutions?
Institutions hold 32.1% of Kazia Therapeutics's shares outstanding; insiders hold 15.42%.
Which funds own Kazia Therapeutics?
The largest fund holders of Kazia Therapeutics are Exemplar Growth and Income Ser FD (1.23%), Fidelity Nasdaq Composite Index (0.03%), ActivePassive International Equity ETF (0.03%).
What is Kazia Therapeutics's short interest?
1.2M shares of Kazia Therapeutics were sold short, 7.56% of the float; at the average daily volume it would take 3.48 days to cover.
Are insiders buying or selling Kazia Therapeutics?
Of the latest 1 reported insider transactions in Kazia Therapeutics (since March 20, 2023), 1 were purchases and 0 were sales.
How many shares of Kazia Therapeutics are outstanding?
Kazia Therapeutics has 11.4M shares outstanding, of which 9.4M are in the public float.